Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Interest Expenses: 2012-2024

Historic Interest Expenses for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to $8,774.

  • Sunshine Biopharma's Interest Expenses fell 71.67% to $8,529 in Q4 2024 from the same period last year, while for Dec 2024 it was $88,065, marking a year-over-year decrease of 22.10%. This contributed to the annual value of $8,774 for FY2024, which is 93.61% down from last year.
  • Per Sunshine Biopharma's latest filing, its Interest Expenses stood at $8,774 for FY2024, which was down 93.61% from $137,308 recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Interest Expenses peaked at $328,818 during FY2021, and registered a low of $8,774 during FY2024.
  • Moreover, its 3-year median value for Interest Expenses was $39,412 (2022), whereas its average is $61,831.
  • Per our database at Business Quant, Sunshine Biopharma's Interest Expenses skyrocketed by 248.39% in 2023 and then tumbled by 93.61% in 2024.
  • Sunshine Biopharma's Interest Expenses (Yearly) stood at $168,105 in 2020, then surged by 95.60% to $328,818 in 2021, then tumbled by 88.01% to $39,412 in 2022, then skyrocketed by 248.39% to $137,308 in 2023, then tumbled by 93.61% to $8,774 in 2024.